Manulife (Manufacturers Life Insurance)’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-19,985
| Closed | -$188K | – | 3072 |
|
|
2020
Q3 | $188K | Hold |
19,985
| – | – | ﹤0.01% | 2596 |
|
|
2020
Q2 | $151K | Sell |
19,985
-2,363
| -11% | -$18.1K | ﹤0.01% | 2612 |
|
|
2020
Q1 | $138K | Buy |
22,348
+1,250
| +6% | +$11K | ﹤0.01% | 2475 |
|
|
2019
Q4 | $257K | Sell |
21,098
-1,156
| -5% | -$12.6K | ﹤0.01% | 2427 |
|
|
2019
Q3 | $269K | Sell |
22,254
-329
| -1% | -$3.46K | ﹤0.01% | 2398 |
|
|
2019
Q2 | $226K | Sell |
22,583
-774
| -3% | -$8.35K | ﹤0.01% | 2568 |
|
|
2019
Q1 | $300K | Buy |
23,357
+2,179
| +10% | +$32.4K | ﹤0.01% | 2267 |
|
|
2018
Q4 | $321K | Sell |
21,178
-1,808
| -8% | -$34.5K | ﹤0.01% | 2145 |
|
|
2018
Q3 | $460K | Sell |
22,986
-2,804
| -11% | -$63.8K | ﹤0.01% | 2355 |
|
|
2018
Q2 | $503K | Sell |
25,790
-774
| -3% | -$17.1K | ﹤0.01% | 2386 |
|
|
2018
Q1 | $535K | Sell |
26,564
-1,039
| -4% | -$17.6K | ﹤0.01% | 2280 |
|
|
2017
Q4 | $365K | Buy |
27,603
+487
| +2% | +$7.34K | ﹤0.01% | 2544 |
|
|
2017
Q3 | $501K | Buy |
27,116
+16
| +0.1% | +$298 | ﹤0.01% | 2270 |
|
|
2017
Q2 | $499K | Sell |
27,100
-63
| -0.2% | -$1.25K | ﹤0.01% | 2292 |
|
|
2017
Q1 | $612K | Buy |
27,163
+3,320
| +14% | +$79.5K | ﹤0.01% | 2044 |
|
|
2016
Q4 | $830K | Sell |
23,843
-21
| -0.1% | -$627 | ﹤0.01% | 1769 |
|
|
2016
Q3 | $584K | Buy |
23,864
+264
| +1% | +$6.6K | ﹤0.01% | 1974 |
|
|
2016
Q2 | $565K | Buy |
23,600
+1,010
| +4% | +$23.2K | ﹤0.01% | 1946 |
|
|
2016
Q1 | $500K | Buy |
22,590
+456
| +2% | +$10.8K | ﹤0.01% | 1987 |
|
|
2015
Q4 | $668 | Buy |
22,134
+243
| +1% | +$7.85K | ﹤0.01% | 1844 |
|
|
2015
Q3 | $869 | Buy |
21,891
+2,725
| +14% | +$169K | ﹤0.01% | 1674 |
|
|
2015
Q2 | $1.32K | Buy |
19,166
+4,892
| +34% | +$308K | ﹤0.01% | 1541 |
|
|
2015
Q1 | $780 | Buy |
14,274
+352
| +3% | +$16.8K | ﹤0.01% | 1812 |
|
|
2014
Q4 | $593 | Sell |
13,922
-644
| -4% | -$23.3K | ﹤0.01% | 1885 |
|
|
2014
Q3 | $464 | Buy |
14,566
+195
| +1% | +$4.16K | ﹤0.01% | 2038 |
|
|
2014
Q2 | $298K | Sell |
14,371
-2,082
| -13% | -$38.5K | ﹤0.01% | 2426 |
|
|
2014
Q1 | $319 | Sell |
16,453
-21
| -0.1% | -$446 | ﹤0.01% | 2390 |
|
|
2013
Q4 | $400 | Sell |
16,474
-455
| -3% | -$10.7K | ﹤0.01% | 2218 |
|
|
2013
Q3 | $364 | Sell |
16,929
-395
| -2% | -$9.33K | ﹤0.01% | 2199 |
|
|
2013
Q2 | $386K | Buy |
+17,324
| New | +$382K | ﹤0.01% | 2064 |
|
Manulife (Manufacturers Life Insurance)'s AMAG Position: Q4 2020 in Review
Manulife (Manufacturers Life Insurance) sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 19,985 shares — an estimated $188K sold.
Manulife (Manufacturers Life Insurance) first reported a position in AMAG in Q2 2013 and held it in 30 quarters. The position peaked at $830K in Q4 2016. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Manulife (Manufacturers Life Insurance) reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 19,985 AMAG Pharmaceuticals shares in Q4 2020, an estimated $188K.
- Manulife (Manufacturers Life Insurance) first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 30 quarters.
- Manulife (Manufacturers Life Insurance)'s AMAG Pharmaceuticals position peaked at $830K in Q4 2016.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2020, filed 12 Feb 2021.